LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Search

Axonics Inc

Închisă

Sector Sănătate

70.28 0.1

Rezumat

Modificarea prețului

24h

Curent

Minim

70.1

Maxim

70.29

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+1.08 upside

Dividende

By Dow Jones

Următoarele câștiguri

28 oct. 2024

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Axonics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 ian. 2024, 16:21 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Axonics Shares Climb 20% After Acquisition by Boston Scientific

8 ian. 2024, 12:26 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific To Acquire Axonics For About $3.7 Billion

19 sept. 2024, 16:36 UTC

Market Talk

Medtronic Continues Patent Infringement Fight After Losing Lawsuit -- Market Talk

8 ian. 2024, 15:59 UTC

Achiziții, Fuziuni, Preluări

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot' -- IBD

8 ian. 2024, 14:19 UTC

Achiziții, Fuziuni, Preluări

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value -- IBD

8 ian. 2024, 13:18 UTC

Achiziții, Fuziuni, Preluări

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal. -- Barrons.com

8 ian. 2024, 12:12 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Acquisition Impact to GAAP EPS Expected to Be Less Accretive, or More Dilutive, Due to Amortization Expense and Acquisition-Related Net Charges >BSX

8 ian. 2024, 12:12 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Sees Acquisition Impact to Adj EPS Immaterial in 2024 and Accretive Thereafter >BSX

8 ian. 2024, 12:11 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Axonics' Rev Growth Profile Is Anticipated to Be Highly Accretive to BSX Urology Business in 2024 >BSX

8 ian. 2024, 12:11 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Axonics Expects to Deliver Net Rev of About $366 M in 2023 >BSX

8 ian. 2024, 12:11 UTC

Top știri
Achiziții, Fuziuni, Preluări

Boston Scientific To Acquire Axonics For About $3.7 Bln

8 ian. 2024, 12:10 UTC

Achiziții, Fuziuni, Preluări

Axonic's Stock Soars After Cash Buyout Deal With Boston Scientific Valued At $3.7 Billion -- MarketWatch

8 ian. 2024, 12:02 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Deal Reflects Equity Value of About $3.7B and Enterprise Value of About $3.4B

8 ian. 2024, 12:02 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Acquisition to Expand Urology Portfolio With Differentiated Technologies to Treat Urinary and Bowel Dysfunction >BSX

8 ian. 2024, 12:02 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX

8 ian. 2024, 12:01 UTC

Achiziții, Fuziuni, Preluări

Axonics to Be Acquired for $71/Share; Closed Friday at $57.57 >BSX AXNX

8 ian. 2024, 12:01 UTC

Achiziții, Fuziuni, Preluări

Axonics to Be Acquired by Boston Scientific for About $3.7 Billion >BSX AXNX

8 ian. 2024, 12:01 UTC

Achiziții, Fuziuni, Preluări

Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX

8 ian. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Announces Agreement To Acquire Axonics, Inc. >BSX AXNX

8 ian. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Axonics Announces Definitive Agreement To Be Acquired By Boston Scientific >AXNX BSX

Comparație

Modificare preț

Axonics Inc Așteptări

Obiectiv de preț

By TipRanks

1.08% sus

Prognoză pe 12 luni

Medie 71 USD  1.08%

Maxim 71 USD

Minim 71 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAxonics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

3 ratings

0

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

70.195 / 70.3Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

No Evidence

Termen lung

Weak Bullish Evidence

Date financiare

$